University of Nottingham CiC#6 : accelerating translation of novel, early-stage, interdisciplinary, biomedical research

Lead Research Organisation: University of Nottingham
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

The Confidence in Concept scheme is a key part of MRC’s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach –– before seeking more substantive funding. It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.

Publications

10 25 50
 
Description National consensus document on mild traumatic brain injury
Geographic Reach National 
Policy Influence Type Contribution to a national consultation/review
URL https://spiral.imperial.ac.uk/handle/10044/1/81286
 
Description Development and validation of a multi-parameter sensor for resuscitation of high-risk newborns
Amount £1,019,507 (GBP)
Organisation National Institute for Health Research 
Sector Public
Country United Kingdom
Start 02/2023 
End 08/2025
 
Description Impact Accelerator Award to Ruth Griffin
Amount £64,779 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 01/2023 
End 12/2023
 
Description Innovate UK CPI funding to Prof. Jackson / Neurotherapeutics
Amount £30,000 (GBP)
Organisation Innovate UK 
Sector Public
Country United Kingdom
Start  
 
Description Medilink funding to Neurotherapeutics
Amount £147,000 (GBP)
Organisation East Midlands Medilink 
Sector Private
Country United Kingdom
Start  
 
Description Military Traumatic Brain Injury Biomarker Study, A Prospective Cohort Biomarker Study Of Military And Civilian Participants With MTBI
Amount £195,548 (GBP)
Organisation Ministry of Defence (MOD) 
Sector Public
Country United Kingdom
Start 12/2021 
End 05/2023
 
Description Multi-package approach to priming key neonatal technologies
Amount £24,661 (GBP)
Organisation National Institute for Health Research 
Sector Public
Country United Kingdom
Start 09/2021 
End 04/2023
 
Description Next Generation Multiparameter Vital Signs Monitoring For Newborns
Amount £531,163 (GBP)
Organisation Innovate UK 
Sector Public
Country United Kingdom
Start 01/2023 
End 12/2024
 
Description Novel delivery routes for c.difficile vaccines
Amount £50,000 (GBP)
Organisation United Kingdom Research and Innovation 
Sector Public
Country United Kingdom
Start 01/2020 
End 06/2021
 
Description Research Enablement Award to Dr. Helen Betts
Amount £10,000 (GBP)
Organisation Royal Society of Chemistry 
Sector Charity/Non Profit
Country United Kingdom
Start  
 
Description Splitting STAT Dimers to Understand Interferon Balance: A Strategy to Dissociate Beneficial and Detrimental Interferon Effects in Infection?
Amount £715,073 (GBP)
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 04/2021 
End 05/2024
 
Description Development and initial validation of the next generation newborn resuscitation monitoring device to improve outcomes for high-risk infants 
Organisation Surepulse Medical Limited
Country United Kingdom 
Sector Private 
PI Contribution Our co-funded clinical research fellow supports study setup/running and data collection, our research nurse assists training, patient recruitment and data collection and we also supply consumables . Furthermore, our leadership team provide the medical and some associated engineering technical expertise.
Collaborator Contribution Sure Pulse medical have provided funding for a Clinical research fellow (£34K), and in-kind support to provide access to an engineer (0.2wte £8.3K)
Impact Project is still in progress. Outcomes not yet realised. Collaboration is multi-disciplinary,
Start Year 2018
 
Description Multi-parameter newborn sensor project 
Organisation Tioga Ltd, Derby
Country United Kingdom 
Sector Private 
PI Contribution Partner on Innovate UK grant
Collaborator Contribution Partner on Innovate UK grant
Impact None as yet
Start Year 2022
 
Title Azetidine derivatives for the treatment of integrin associated diseases 
Description Azetidine derivatives for the treatment of integrin associated diseases 
IP Reference WO 2022/008918 (A1) 
Protection Patent / Patent application
Year Protection Granted 2021
Licensed Commercial In Confidence
Impact Azetidine derivatives for the treatment of integrin associated diseases
 
Title THERAPEUTIC COMPOUNDS 
Description The invention provides a product which is a compound of formula (I), or a pharmaceutically acceptable salt, hydrate or solvate thereof: (I) wherein: X is selected from: hydrogen; a methyl group which is optionally substituted, wherein any substituent groups present are independently selected from hydroxyl, halo and NR'2, where each R' is independently selected from hydrogen and methyl; and an ethyl group which is either unsubstituted or is substituted with from one to five F substituent groups; Y is selected from: hydrogen; a methyl group which is optionally substituted, wherein any substituent groups present are independently selected from hydroxyl, halo and NR'2, where each R' is independently selected from hydrogen and methyl; and an ethyl group which is either unsubstituted or is substituted with from one to five F substituent groups; RA is hydrogen, or is a C1-2 alkyl group which is optionally substituted, wherein any substituent groups present are independently selected from hydroxyl, halo and NR'2, where each R' is independently selected from hydrogen and methyl. 
IP Reference WO2020240199 
Protection Patent application published
Year Protection Granted 2020
Licensed No
Impact None as yet
 
Company Name Neurotherapeutics Ltd 
Description  
Year Established 2019 
Impact https://www.nottingham.ac.uk/news/spin-out-company-launched-deliver-wrist-device-control-tourettes